Alpha Tau Medical (DRTS)

• Market cap: $181M
• 1 day: 1.58%
• 5 days: 2.80%
• 1 month: -3.38%
• 3 months: -34.27%
• 6 months: 11.74%
• Year to date: -17.10%
• 1 year: -4.46%
• 5 years: -78.42%
• 10 years: -78.42%
• Sector: Healthcare
• Industry: Biotechnology

About: Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company derives maximum revenue from Israel.

Employees: 125

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

36% more capital invested

Capital invested by funds: $2.23M [Q3] → $3.03M (+$797K) [Q4]

33% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 3

0.04% more ownership

Funds ownership: 1.36% [Q3] → 1.4% (+0.04%) [Q4]

9% less funds holding

Funds holding: 23 [Q3] → 21 (-2) [Q4]

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $9 250% upside
• Avg. target: $9 250% upside
• High target: $9 250% upside

1 analyst rating

• positive: 1 100%
• neutral: 0 0%
• negative: 0 0%

HC Wainwright & Co. Yi Chen 27% 1-year accuracy 46 / 173 met price target

250% upside $9

Buy Reiterated

17 Mar 2025